Angela Kortesidis

Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells

A. Zannettino, I. Kratchmarova, O. Jensen, 2011, Molecules and cells.

Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

A. Zannettino, L. To, T. Lapidot, 2005 .

Elevated Serum Levels of Stromal-Derived Factor-1A Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

L. To, T. Lapidot, Sally K. Martin, 2005 .

Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.

A. Zannettino, L. To, T. Lapidot, 2005, Cancer research.

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow

S. Gronthos, A. Zannettino, S. Shi, 2003, Journal of Cell Science.

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

T. Lapidot, S. Gronthos, A. Zannettino, 2005, Blood.

Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis.

Li Zhang, Matthew R Allen, Stan Gronthos, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Human mulipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1bright/CD34−/CD45−/glycophorin-A-bone marrow cells

S. Gronthos, A. Zannettino, S. Paton, 2007, Haematologica.